Livforsakringsbolaget Skandia, Omsesidigt Dexcom Inc Transaction History
Livforsakringsbolaget Skandia, Omsesidigt
- $1.73 Billion
- Q1 2025
A detailed history of Livforsakringsbolaget Skandia, Omsesidigt transactions in Dexcom Inc stock. As of the latest transaction made, Livforsakringsbolaget Skandia, Omsesidigt holds 3,387 shares of DXCM stock, worth $289,520. This represents 0.01% of its overall portfolio holdings.
Number of Shares
3,387
Previous 3,387
-0.0%
Holding current value
$289,520
Previous $263,000
12.17%
% of portfolio
0.01%
Previous 0.01%
Shares
12 transactions
Others Institutions Holding DXCM
# of Institutions
1,080Shares Held
363MCall Options Held
5.4MPut Options Held
4.3M-
Vanguard Group Inc Valley Forge, PA47.5MShares$4.06 Billion0.06% of portfolio
-
Black Rock Inc. New York, NY34.5MShares$2.95 Billion0.09% of portfolio
-
State Street Corp Boston, MA16.7MShares$1.43 Billion0.05% of portfolio
-
Baillie Gifford & CO14.2MShares$1.21 Billion0.87% of portfolio
-
Capital Research Global Investors Los Angeles, CA12MShares$1.03 Billion0.19% of portfolio
About DEXCOM INC
- Ticker DXCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 386,257,984
- Market Cap $33B
- Description
- DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...